Publications by authors named "Jenny Potratz"

21Publications

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma.

Cancers (Basel) 2020 Apr 7;12(4). Epub 2020 Apr 7.

Department of Pediatric Hematology and Oncology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12040904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226494PMC
April 2020

Research priorities in pediatric onco-critical care: an international Delphi consensus study.

Intensive Care Med 2019 11 23;45(11):1681-1683. Epub 2019 Aug 23.

Department of Pediatric Intensive Care, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00134-019-05706-xDOI Listing
November 2019

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling.

Cell Commun Signal 2018 05 18;16(1):21. Epub 2018 May 18.

Department of General Pediatrics, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12964-018-0233-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960216PMC
May 2018

Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.

Anticancer Drugs 2016 11;27(10):1001-10

Departments of aPediatric Hematology and Oncology bGeneral Pediatrics, University Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000418DOI Listing
November 2016

Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines.

Anticancer Drugs 2015 Sep;26(8):843-51

aDepartment of Pediatric Hematology and Oncology bGerhard-Domagk Institute of Pathology, University Hospital Münster, Münster cInstitute for Experimental Cancer Research in Pediatrics, Goethe-University, Frankfurt dSuabian Children's Cancer Center, Children's Hospital Augsburg, Augsburg, Germany.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CAD.0000000000000256DOI Listing
September 2015

Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function.

Oncol Rep 2014 Aug 13;32(2):845-52. Epub 2014 Jun 13.

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, D-48149 Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2014.3269DOI Listing
August 2014

Ewing sarcoma: biology-based therapeutic perspectives.

Pediatr Hematol Oncol 2012 Feb;29(1):12-27

Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2011.627582DOI Listing
February 2012

Ewing sarcoma: clinical state-of-the-art.

Pediatr Hematol Oncol 2012 Feb;29(1):1-11

Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2011.622034DOI Listing
February 2012

Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group.

Oral Oncol 2008 Mar 27;44(3):286-94. Epub 2007 Apr 27.

Universitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2007.03.001DOI Listing
March 2008

In vivo analyses of UV-irradiation-induced p53 promoter binding using a novel quantitative real-time PCR assay.

Int J Oncol 2005 Feb;26(2):493-8

Department of Medicine, Hematology and Oncology, University of Münster, D-48149 Münster, Germany.

View Article

Download full-text PDF

Source
February 2005